Evaluation of the Effectiveness and Efficiency of Minimally Invasive Craniotomy in the Treatment of Cerebral Hemorrhage

Abstract

Objective: To investigate the clinical effect of minimally invasive craniotomy in the treatment of patients with cerebral hemorrhage. Methods: 58 samples of patients with cerebral hemorrhage admitted to the hospital were extracted, and the enrollment time was from January 2023 to December 2023. The patients were grouped into an observation group (n = 29) and a control group (n = 29) by using the random draw method of the numerical table. Patients in the control group underwent traditional craniotomy, while patients in the observation group underwent minimally invasive craniotomy, comparing the clinical effectiveness rate, operation time, hematoma clearance rate, rebleeding rate, hospital stay, and various functional scores between the two groups. Results: The clinical efficiency of the observation group was higher than that of the control group (P < 0.05); the operation time and hospital stay of the observation group were lower than that of the control group (P < 0.05); there was no significant difference in the hematoma clearance rate and rebleeding rate of the two groups (P > 0.05); the neurological impairment score of the observation group was lower than that of the control group after the operation, and the Barthel index of daily living score, cognitive functioning score (HDS), dementia scale score of the observation group were lower than that of the control group (P > 0.05). Dementia scale scores (HDS) were higher than those of the control group (P < 0.05). Conclusion: Minimally invasive craniotomy is effective in the treatment of patients with cerebral hemorrhage, which can shorten the operation time and hospital stay, improve the recovery of neurological function and daily living ability, and is suitable to be promoted and applied in medical institutions.